Insider · CIK 0001363683

Greenleaf Peter

Reports to the SEC for 10 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001363683

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−797 sh	$21.17	−$16.9K	23,087
2026-07-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−712 sh	$26.00	−$18.5K	23,969
2026-07-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−85 sh	$27.27	−$2,318.231	23,884
2026-04-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−420 sh	$20.52	−$8,616.342	25,058
2026-04-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−377 sh	$21.36	−$8,053.248	24,681
2026-03-02	AUPHAurinia Pharmaceuticals Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−101K sh	$14.21	−$1.43M	1,840,379
2026-02-27	AUPHAurinia Pharmaceuticals Inc.A Award	Director, Chief Executive Officer	AAward	+196K sh	—	—	1,941,269
2026-02-27	AUPHAurinia Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+328K sh	—	—	328,424
2026-02-20	AUPHAurinia Pharmaceuticals Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−100K sh	$14.40	−$1.44M	1,744,866
2026-01-02	AUPHAurinia Pharmaceuticals Inc.A Award	Director, Chief Executive Officer	AAward	+165K sh	—	—	1,954,329
2026-01-02	AUPHAurinia Pharmaceuticals Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−113K sh	$15.95	−$1.81M	1,845,037
2025-07-02	PTHSPelthos Therapeutics Inc.A Award	Director	AAward	+25.5K sh	—	—	25,478
2025-07-02	PTHSPelthos Therapeutics Inc. · Restricted Stock UnitsA Award	Director	AAward	+25.5K sh	—	—	25,478
2025-07-02	PTHSPelthos Therapeutics Inc. · Stock OptionA Award	Director	AAward	+77.6K sh	—	—	77,640
2025-03-04	AUPHAurinia Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−165K sh	$7.92	−$1.31M	1,788,945
2025-03-03	AUPHAurinia Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−196K sh	$8.00	−$1.56M	1,953,892
2025-03-03	AUPHAurinia Pharmaceuticals Inc.A Award	Director, Chief Executive Officer	AAward	+334K sh	—	—	2,149,485
2025-02-28	AUPHAurinia Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+444K sh	—	—	443,973
2025-02-28	AUPHAurinia Pharmaceuticals Inc.A Award	Director, Chief Executive Officer	AAward	+291K sh	—	—	1,815,780
2024-03-06	AUPHAurinia Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−127K sh	$5.60	−$711K	1,522,114
2024-02-20	AUPHAurinia Pharmaceuticals Inc.A Award	Director, Chief Executive Officer	AAward	+662K sh	—	—	1,649,095
2023-03-02	AUPHAurinia Pharmaceuticals Inc.A Award	Director, Chief Executive Officer	AAward	+667K sh	—	—	1,015,718
2023-03-02	AUPHAurinia Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−33K sh	$8.78	−$290K	982,671
2023-03-02	AUPHAurinia Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−32.8K sh	$8.94	−$293K	982,968
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48.5K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−58.2K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46.7K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−49.4K sh	$5.60	−$277K	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−30.2K sh	$5.60	−$169K	0
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−27.7K sh	—	—	0
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−114K sh	—	—	0
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCJ Other	Director	JOther	−105K sh	—	—	0
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−64.2K sh	—	—	0
2022-03-02	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+534K sh	—	—	534,188
2022-03-02	AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+312K sh	—	—	312,240
2022-03-02	AUPHAurinia Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−9,068 sh	$12.01	−$109K	32,967
2022-03-02	AUPHAurinia Pharmaceuticals Inc.A Award	Director, Chief Executive Officer	AAward	+28.3K sh	—	—	42,035
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)A Award	Director	AAward	+114K sh	$3.66	+$419K	114,347
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsA Award	Director	AAward	+20.5K sh	—	—	20,492
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10.2K sh	—	—	10,246
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+10.2K sh	—	—	105,034
2021-08-06	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	17,500
2021-08-06	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+35K sh	—	—	94,788
2021-06-10	ANTARES PHARMA, INC.A Award	Director	AAward	+25.5K sh	$4.42	+$112K	79,645
2021-06-10	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+48.5K sh	—	—	48,542
2021-05-11	AUPHAurinia Pharmaceuticals Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,992 sh	$11.11	+$33.2K	13,453
2021-05-11	AUPHAurinia Pharmaceuticals Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,133 sh	$10.15	+$21.6K	10,461
2020-08-07	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+35K sh	—	—	59,788
2020-08-07	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	52,500

Recent filings

Accepted (ET)
Oct 64
Greenleaf Peter0001919246-26-000131
SEC(opens sec.gov)
Jul 74
Greenleaf Peter0001919246-26-000100
SEC(opens sec.gov)
Apr 64
Greenleaf Peter0001919246-26-000052
SEC(opens sec.gov)
Apr 14/A
Greenleaf Peter0001919246-26-000043
SEC(opens sec.gov)
Mar 34
Greenleaf Peter0001600620-26-000021
SEC(opens sec.gov)
Feb 234
Greenleaf Peter0001363683-26-000002
SEC(opens sec.gov)
Jan 54
Greenleaf Peter0001600620-26-000002
SEC(opens sec.gov)
Jul 74
Greenleaf Peter0001753926-25-001108
SEC(opens sec.gov)
Mar 44
Greenleaf Peter0001600620-25-000024
SEC(opens sec.gov)
Mar 74
Greenleaf Peter0001600620-24-000038
SEC(opens sec.gov)

Companies

Address

C/O PELTHOS THERAPEUTICS INC. 4020 STIRRUP CREEK DRIVE, SUITE 110

DURHAM, NC, 27703